Open Government Portal

Found 10 records similar to Country access to Canada's Access to Medicines Regime

Federal

To participate in the Regime, an eligible importing country must declare that it has insufficient or no pharmaceutical manufacturing capacity in relation to the specific product it is requesting. It is up to each country to determine for itself the level of its manufacturing capacity.

Last Updated: Sep. 17, 2020
Date Published: Mar. 29, 2017
Organization: Health Canada
Formats: HTML
Keywords:  Canada's Access to Medicines Regime, manufacturing capacity, eligible importing country, insufficient or no pharmaceutical manufacturing capacity.
Federal

It presents the list Least-Developed Countries Eligible to Import Under the Regime.

Last Updated: Sep. 17, 2020
Date Published: Mar. 17, 2017
Organization: Health Canada
Formats: HTML
Keywords:  Canada's Access to Medicines Regime, Least-developed countries, countries eligible to import under the Regime.
Federal

It presents WTO-Member Countries and Non-WTO Member Countries Eligible to Import Under the Regime.

Last Updated: Sep. 17, 2020
Date Published: Mar. 17, 2017
Organization: Health Canada
Formats: HTML
Keywords:  Canada's Access to Medicines Regime, WTO-member countries, non-WTO member countries, countries eligible to import under the Regime.
Federal

Canada's Access to Medicines Regime provides a framework within which eligible countries can import less expensive generic versions of patented drugs and medical devices.

Last Updated: Sep. 17, 2020
Date Published: Mar. 23, 2017
Organization: Health Canada
Formats: HTML
Keywords:  Canada's Access to Medicines Regime, developing and least-developed countries, import less expensive generic drugs, patented drugs and medical devices.
Federal

Below are some of the unique features of Canada's Access to Medicines Regime, many of which resulted from negotiations between the Government of Canada, the private sector and various non-governmental organizations.

Last Updated: Sep. 17, 2020
Date Published: Mar. 28, 2017
Organization: Health Canada
Formats: HTML
Keywords:  Canada's Access to Medicines Regime, World Trade Organization, negotiations between the Government of Canada, the private sector and non-governmental organizations.
Federal

It presents WTO-Member Countries Eligible to Import Under the Regime

Last Updated: Sep. 17, 2020
Date Published: Mar. 17, 2017
Organization: Health Canada
Formats: HTML
Keywords:  Canada's Access to Medicines Regime, WTO-member countries, countries eligible to import under the Regime.
Federal

The Government of Canada regards non-governmental organizations (NGOs) as valuable resources and actively consulted with them when designing Canada's Access to Medicines Regime.

Last Updated: Sep. 17, 2020
Date Published: Mar. 17, 2017
Organization: Health Canada
Formats: HTML
Keywords:  Canada's Access to Medicines Regime, role of Non-Governmental Organizations
Federal

Canada's Access to Medicines Regime provides a way for the world's developing and least-developed countries to import high-quality drugs and medical devices at a lower cost to treat the diseases that bring suffering to their citizens.

Last Updated: Sep. 17, 2020
Date Published: Apr. 25, 2017
Organization: Health Canada
Formats: HTML
Keywords:  Canada's Access to Medicines Regime, developing and least-developed countries, import high-quality drugs and medical devices, a lower cost drug and medical devices.
Federal

To participate in the Regime, a pharmaceutical company must enter into a sales agreement with an eligible importing country for the purchase of a specified amount of an eligible product listed on Schedule 1. A pharmaceutical company must also submit an application for authorization to Canada's Commissioner of Patents. Once the authorization or compulsory licence is issued, there are additional terms and conditions that the company must meet and maintain.

Last Updated: Sep. 17, 2020
Date Published: Mar. 29, 2017
Organization: Health Canada
Formats: HTML
Keywords:  Company requirements under Canada's Access to Medicines Regime, sales agreement, compulsory licence, eligible importing country, eligible product, application for authorization to Canada's Commissioner of Patents.
Federal

This process map provides a visual overview of the steps that need to be followed by a pharmaceutical company that is preparing to submit an application for a compulsory licence under Canada's Access to Medicines Regime.

Last Updated: Sep. 17, 2020
Date Published: Apr. 28, 2017
Organization: Health Canada
Formats: HTML
Keywords:  Process map, application under Canada's Access to Medicines Regime, application for a compulsory licence.
Date modified: